IASLC > International Association for the Study of Lung Cancer > Conferences & Events > Event Details
Women and Lung Cancer: Screening, Treatment and Beyond
August 29, 2019 | Online


This one hour program will feature 3 presentations and provide ample time for questions and discussion. This webinar will discuss the global impact of lung cancer on women and the changing landscape from past, current, and future. Recent analysis from multiple large lung cancer screening trials confirm the objective curative benefit of lung cancer screening and results suggest this benefit is considerately greater in women; the magnitude of these favorable outcomes far exceed the mortality benefit previously reported with breast or colon cancer screening. Low dose CT screening especially integrated with comprehensive tobacco cessation is a remarkable potent tool for improving health of tobacco-exposed individuals but especially impactful with women. Differences in gender will be discussed regarding lung cancer in never smokers, susceptibility to cigarette smoke, lung cancer development, and response to screening and treatment. Future directions in lung cancer research and screening will be reviewed. 

Program Sponsors: 


What you should expect to learn

  • Understand the global burden of lung cancer in women and how it differs from males
  • Discuss the importance of lung cancer screening in the female population to detect lung cancer earlier when it's more easily treated with significant improved survival
  • Describe treatment for lung cancer in women and gender differences in response and survival
  • Provide an overview for future directions regarding lung cancer screening and research

James L. Mulshine, MD
Chair, Screening and Early Detection Committee, IASLC
Rush University, Chicago

Mary Pasquinelli, DNP, FNP-BC: Presenting: The Global Burden of Lung Cancer in Women, What Do we Know?
Adjunct Clinical Instructor - UIC College of Nursing
Director, Lung Cancer Screening Program
Advanced Practice Nurse, Pulmonary and Medical Oncology
University of Illinois Hospital & Health Science System (UI Health)

Claudia I. Henschke, PhD, MD: Presenting: Lung Screening for Women- Susceptibility and Cure Rates
Department of Radiology
Director, Early Lung and Cardiac Program
The Icahn School of Medicine at Mount Sinai
New York, NY  

Andrea S. Wolf, MD, MPH: Presenting: Treatment of Lung Cancer: Does Gender Matter?
Associate Professor
Director, New York Mesothelioma Program
Department of Thoracic Surgery
The Icahn School of Medicine at Mount Sinai
New York, NY



Member Experience Department